Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Volume 1867, Issue 1, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.bbadis.2020.165939
Keywords
eIF5A; Hypusination; TDP-43; Cytoplasmic accumulation; Stress granule; Nuclear import; Proteinopathy
Funding
- College of Pharmacy Start-up Funds, University of South Florida FL, USA
- COP New Investigator Seed Grant, University of South Florida FL, USA
Ask authors/readers for more resources
TDP-43 protein interacts with eIF5A(Hyp)(K50), and this interaction is enhanced under stress conditions. Decreasing hypusination or mutating lysine residues reduces abnormal levels of TDP-43. Importins KPNA1/2, KPNB1, and RanGTP were also identified as interacting partners of eIF5A(Hyp)(K50).
TAR DNA-binding protein 43 (TDP-43) is a nuclear RNA/DNA binding protein involved in mRNA metabolism. Aberrant mislocalization to the cytoplasm and formation of phosphorylated/aggregated TDP-43 inclusions remains the hallmark pathology in a spectrum of neurodegenerative diseases, including frontotemporal disorders and Alzheimer's disease. Eukaryotic Translation Initiation Factor 5A undergoes a unique post-translation modification of lysine to hypusine (K50), which determines eIF5A binding partners. We used a sodium arseniteinduced cellular stress model to investigate the role of hypusinated eIF5A (eIF5A(Hyp)(K50)) in governing TDP-43 cytoplasmic mislocalization and accumulation in stress granule. Our proteomics and functional data provide evidence that eIF5A interacts with TDP-43 in a hypusine-dependent manner. Additionally, we showed that following stress TDP-43 interactions with eIF5A(Hyp)(K50) were induced both in the cytoplasm and stress granules. Pharmacological reduction of hypusination or mutations of lysine residues within the hypusine loop decreased phosphorylated and insoluble TDP-43 levels. The proteomic and biochemical analysis also identified nuclear pore complex importins KPNA1/2, KPNB1, and RanGTP as interacting partners of eIF5A(Hyp)(K50). These findings are the first to provide a novel pathway and potential therapeutic targets that require further investigation in models of TDP-43 proteinopathies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available